MeSH term
Frequency | Condition_Probility | Alleles | 12 | 0.0 |
Blood Group Antigens/*genetics | 8 | 7.0 |
Chi-Square Distribution | 2 | 0.0 |
Cluster Analysis | 2 | 1.0 |
Ethnic Groups/*genetics | 3 | 1.0 |
Gene Frequency | 23 | 0.0 |
Haplotypes | 3 | 0.0 |
Humans | 104 | 0.0 |
Phenotype | 29 | 0.0 |
*Polymorphism, Genetic | 21 | 0.0 |
Research Support, Non-U.S. Gov't | 55 | 0.0 |
Animals | 19 | 0.0 |
Male | 34 | 0.0 |
Rats | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Blood Group Antigens/genetics | 3 | 5.0 |
China | 2 | 0.0 |
English Abstract | 7 | 0.0 |
*Gene Frequency | 12 | 2.0 |
Glucosephosphate Dehydrogenase/genetics | 2 | 2.0 |
Base Sequence | 10 | 0.0 |
Mice | 6 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Adult | 13 | 0.0 |
Comparative Study | 15 | 0.0 |
Enzymes/*genetics | 4 | 9.0 |
Erythrocytes/*enzymology | 17 | 3.0 |
Female | 32 | 0.0 |
Genetic Markers | 18 | 0.0 |
Spain | 5 | 1.0 |
*Variation (Genetics) | 3 | 0.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
Ecuador | 2 | 18.0 |
Emigration and Immigration | 2 | 4.0 |
Enzymes/genetics | 3 | 9.0 |
*Chromosomes, Human, Pair 9 | 13 | 5.0 |
Cloning, Molecular | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Infant | 4 | 0.0 |
Nail-Patella Syndrome/*genetics | 4 | 25.0 |
Translocation, Genetic | 2 | 0.0 |
*Genes, Structural | 8 | 0.0 |
Species Specificity | 2 | 0.0 |
*Translocation, Genetic | 4 | 0.0 |
Adenylate Kinase/genetics | 10 | 41.0 |
Gene Frequency/*genetics | 2 | 1.0 |
Genetic Markers/*genetics | 2 | 1.0 |
History, Ancient | 2 | 11.0 |
Multivariate Analysis | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 3 | 0.0 |
Vitamin D-Binding Protein/genetics | 2 | 7.0 |
Cattle | 4 | 0.0 |
Chromosome Mapping | 21 | 0.0 |
DNA | 2 | 0.0 |
Acid Phosphatase/genetics | 3 | 9.0 |
Adenosine Deaminase/genetics | 3 | 13.0 |
*Carboxylesterase | 3 | 2.0 |
Carboxylic Ester Hydrolases/genetics | 3 | 10.0 |
Erythrocytes/enzymology | 4 | 1.0 |
Italy | 5 | 0.0 |
Lactoylglutathione Lyase/genetics | 3 | 6.0 |
Phosphoglucomutase/genetics | 3 | 6.0 |
Binding Sites | 3 | 0.0 |
Kinetics | 3 | 0.0 |
Mutation | 3 | 0.0 |
*Chromosome Mapping | 8 | 0.0 |
Genotype | 2 | 0.0 |
Linkage (Genetics) | 13 | 0.0 |
Pedigree | 6 | 0.0 |
Adolescent | 4 | 0.0 |
Aged | 4 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 3 | 0.0 |
*Genetics, Population | 5 | 1.0 |
Infant, Newborn | 3 | 0.0 |
Middle Aged | 7 | 0.0 |
Polymorphism, Genetic | 11 | 0.0 |
Pregnancy | 3 | 0.0 |
European Continental Ancestry Group/*genetics | 2 | 0.0 |
Blood Proteins/*genetics | 8 | 4.0 |
Europe | 2 | 0.0 |
*Genetic Markers | 5 | 1.0 |
Blood Proteins/genetics | 3 | 5.0 |
Restriction Mapping | 2 | 0.0 |
Tuberous Sclerosis/*genetics | 3 | 3.0 |
Acid Phosphatase/*genetics | 3 | 8.0 |
Adenylate Kinase/*genetics | 15 | 68.0 |
*Indians, South American | 2 | 8.0 |
Inuits/*genetics | 2 | 15.0 |
Lod Score | 3 | 0.0 |
Cell Fusion | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
Hamsters | 8 | 0.0 |
*Polymorphism, Restriction Fragment Length | 3 | 0.0 |
*Linkage (Genetics) | 8 | 0.0 |
DNA/*genetics | 2 | 0.0 |
*Chromosome Aberrations | 3 | 0.0 |
Chromosome Deletion | 3 | 0.0 |
Karyotyping | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Isoelectric Focusing | 3 | 0.0 |
Chromosome Disorders | 2 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Recombination, Genetic | 6 | 0.0 |
Yugoslavia | 2 | 11.0 |
European Continental Ancestry Group/genetics | 4 | 0.0 |
DNA Probes | 2 | 0.0 |
Hybrid Cells | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Lactoylglutathione Lyase/*genetics | 2 | 4.0 |
Oxidoreductases/*genetics | 2 | 2.0 |
Muscles/enzymology | 2 | 3.0 |
Isoenzymes/*genetics | 2 | 0.0 |
Phosphotransferases/*genetics | 15 | 34.0 |
*Ethnic Groups | 3 | 2.0 |
Phosphogluconate Dehydrogenase/genetics | 4 | 15.0 |
Israel | 2 | 1.0 |
Acid Phosphatase/blood/genetics | 2 | 28.0 |
Phosphoglucomutase/*genetics | 3 | 2.0 |
Enzymes/blood/*genetics | 2 | 33.0 |
Sex Factors | 2 | 0.0 |
Adenosine Deaminase/*genetics | 2 | 8.0 |
Nucleoside Deaminases/*genetics | 2 | 13.0 |
ABO Blood-Group System/*genetics | 2 | 4.0 |
Adenylate Kinase/*genetics/metabolism | 2 | 100.0 |
Electrophoresis | 3 | 1.0 |
Syndrome | 2 | 0.0 |
*Chromosomes, Human, 6-12 and X | 11 | 7.0 |
Isoenzymes/analysis | 2 | 3.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
European Continental Ancestry Group | 2 | 0.0 |
HLA Antigens/*genetics | 2 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
India | 2 | 0.0 |
Aconitate Hydratase/*genetics | 3 | 37.0 |
Hybrid Cells/enzymology | 4 | 7.0 |
*ABO Blood-Group System | 3 | 7.0 |
Adenylate Kinase/*blood | 2 | 66.0 |
Phosphotransferases/*blood | 2 | 25.0 |
*Adenylate Kinase | 3 | 100.0 |
Genes | 2 | 0.0 |
*Phosphotransferases | 3 | 50.0 |
